ArticleRSC medicinal chemistry2026

ZRMQ-22, a novel DYRK1A inhibitor, attenuates neuroinflammation and cognitive impairments in LPS-induced mice: a potential strategy for Alzheimer's disease.

Mengyu Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.